Back to Search

PAUL F SIAMI MD

MD

Urology Physician

NPI: 1639228513Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

01039135A(IN)

Clinical Trials (2)

2
Linked Trials
0
Recruiting
2
With Results

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

NCT00701779COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)

NCT00939120COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (12)

Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design.
PMID 17761460·Contemp Clin Trials·2007
4-observational
A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT).
PMID 12017406·Clin Ther·2002
3-trial
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
PMID 19013011·Eur Urol·2009
4-observational
Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH.
PMID 18813219·Prostate Cancer Prostatic Dis·2009
4-observational
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
PMID 19239460·BJU Int·2009
4-observational
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
PMID 19366272·Clin Drug Investig·2009
2-rct
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
PMID 19014833·Clin Ther·2008
3-trial
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
PMID 18082216·J Urol·2008
4-observational
Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study.
PMID 16879437·BJU Int·2006
3-trial
Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5alpha-reductase inhibitor dutasteride: results of 4-year studies.
PMID 16104912·BJU Int·2005
3-trial
Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
PMID 11843992·J Am Geriatr Soc·2001
3-trial
Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group.
PMID 10869641·Urology·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
421 CHESTNUT ST
EVANSVILLE, IN 47713
Practice locations map

Location

BOARD OF TRUSTEES OF WELBORN CLINIC

421 CHESTNUT ST, EVANSVILLE, IN
(812) 426-9855

Quick Facts

NPI
1639228513
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
2
Publications
12

Are you this provider?

Claim Your Profile